FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicinal agents and concerns a composition for preparing a medicinal agent for local treatment of inflammations, containing at least, one glucocorticoid and N-chlorotaurine or N-chlorotaurine salt. There is also discovered a medicinal agent containing specified composition and application of the composition for preparing a medicated mixture for local treatment of inflammations.
EFFECT: lowered profile of (toxic) by-effects.
13 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD TO TREAT PERIPHERAL LESIONS OF FACIAL NERVE | 1995 |
|
RU2104056C1 |
METHOD AND PHARMACEUTICAL COMPOSITION FOR ANTIPHLOGISTIC AGENT DELIVERY | 2004 |
|
RU2325189C2 |
DISPERSIBLE PREPARATION OF ANTIINFLAMMATION AGENT | 2004 |
|
RU2319508C2 |
APPLICATION OF CALCITONIN AS COMBINED THERAPY FOR TREATMENT OF INFLAMMATORY DISEASE STATES | 2006 |
|
RU2394591C2 |
INHIBITING OF STAT-1 | 2002 |
|
RU2311910C2 |
MODULATION OF EXPRESSION OF STAT-1-DEPENDED GENES | 2002 |
|
RU2311456C2 |
COMBINATIONS FOR TREATMENT OF INFLAMMATORY DISEASES | 2002 |
|
RU2300379C2 |
METHOD FOR COMBATTING OTITIS MEDIA AND OTITIS EXTERNA | 2019 |
|
RU2749857C1 |
COMBINED PHARMACEUTICAL COMPOSITION FOR EXTERNAL APPLICATION | 2018 |
|
RU2736940C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFLAMMATORY ILLNESS OR ILLNESSES ASSOCIATED WITH RESPIRATORY WAY OBSTRUCTION | 1992 |
|
RU2098122C1 |
Authors
Dates
2010-09-10—Published
2006-01-12—Filed